Contradictory evidence regarding fibrinolysis [7] and other substances, that could play an important role in the hemostatic deficits observed in the PAH setting (namely soluble thrombomodulin and plasminogen activator inhibitor-1) [36,37] have also been reported. Here, SERPINE1 is linked to pulmonary arterial hypertension.